MediciNova, Inc. announced that on April 20, 2023, Jeff Himawan, Ph.D., a member of the Board of Directors of the company notified the Board that he will not stand for re-election as a Class I director of the Company at the Company's 2023 annual meeting of stockholders due solely to a personal decision related to health reasons.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 USD | +1.47% | -3.60% | -10.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.67% | 64.77M | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- MNOV Stock
- News MediciNova, Inc.
- MediciNova, Inc. Announces Jeff Himawan Not to Stand for Re-Election as a Class I Director